SAN FRANCISCO, CA — Physicians are far more likely to order a VerifyNow (Accumetrics) platelet-function test for their patients with acute MI if the point-of-care assay is offered to them for free, ...
This release is available in Chinese. An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac ...
November 15, 2009 (Orlando, Florida) — Results for the first head-to-head comparison of different platelet-function tests suggests that a handful of platelet reactivity assays--used to test the ...
In a 2-part series, TCTMD will explore how the GRAVITAS trial is influencing the field of functional platelet testing. Part 1 summarizes the trial and its aftermath, including explanations for the ...
Platelet function testing in patients on clopidogrel therapy shows only a weak link between reactivity and stent thrombosis. This drawback could prove to be a serious obstacle to the adoption of such ...
Aspirin is widely prescribed for the secondary prevention of ischemic stroke and acute coronary syndromes, but some patients do not respond to this therapy. There is evidence that these ...
Please provide your email address to receive an email when new articles are posted on . Clopidogrel is often the antiplatelet agent of choice for patients with ACS or those receiving a stent because, ...
CHICAGO – Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine ...
While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...
Study of the bleeding tendency in uremia in 26 subjects, 10 of whom were bleeding, showed platelet counts and plasma coagulation factors to be normal. There was a significant inverse correlation ...
Bleeding because of impaired platelet function is a major side effect of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib. We quantitatively assessed ristocetin-induced platelet aggregation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results